Novel technique of sclerotherapy for superficial lymphatic malformation

PurposeSuperficial lymphatic malformation (SLM), previously known as lymphangioma circumscriptum, is characterized by skin lesions that sometimes require interventional treatment. However, an effective treatment has yet to be established. We proposed an effective sclerotherapy procedure based on the...

Full description

Saved in:
Bibliographic Details
Main Authors: Hidehito Usui, Masato Shinkai, Satoshi Tanaka, Rento Morishima, Kazuki Shirane, Takafumi Kondo, Kyoko Mochizuki, Norihiko Kitagawa
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2025.1614095/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849471598828978176
author Hidehito Usui
Hidehito Usui
Masato Shinkai
Satoshi Tanaka
Rento Morishima
Kazuki Shirane
Takafumi Kondo
Kyoko Mochizuki
Norihiko Kitagawa
author_facet Hidehito Usui
Hidehito Usui
Masato Shinkai
Satoshi Tanaka
Rento Morishima
Kazuki Shirane
Takafumi Kondo
Kyoko Mochizuki
Norihiko Kitagawa
author_sort Hidehito Usui
collection DOAJ
description PurposeSuperficial lymphatic malformation (SLM), previously known as lymphangioma circumscriptum, is characterized by skin lesions that sometimes require interventional treatment. However, an effective treatment has yet to be established. We proposed an effective sclerotherapy procedure based on the pathophysiology of SLM.MethodsSeven patients with SLM who were treated at our hospital between April 2015 and April 2024 were retrospectively enrolled. To maximize the treatment effects, sclerotherapy with bleomycin targeting the SLM and LM deep beneath the SLM was performed.ResultsOf the seven patients, four were females, and three were males. The SLM sites were mucosal lesions in four cases and skin lesions in three cases. The median age at the first sclerotherapy was 10 (1–18) years. A median of one course (1–3) of sclerotherapy resulted in a marked reduction of SLM lesions on gross evaluation to the satisfaction of the patient. The median observation period was 451 (59–2,901) days. No serious complications occurred, except for transient vomiting in one patient and temporary skin pigmentation in two patients. No patient experienced recurrence requiring retreatment.ConclusionOur study suggests that sclerotherapy for the SLM and LM deep beneath the SLM may be an effective treatment for SLM.
format Article
id doaj-art-ed2cf92b37374d7bbb6ecfebc3df689e
institution Kabale University
issn 2296-2360
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj-art-ed2cf92b37374d7bbb6ecfebc3df689e2025-08-20T03:24:47ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602025-06-011310.3389/fped.2025.16140951614095Novel technique of sclerotherapy for superficial lymphatic malformationHidehito Usui0Hidehito Usui1Masato Shinkai2Satoshi Tanaka3Rento Morishima4Kazuki Shirane5Takafumi Kondo6Kyoko Mochizuki7Norihiko Kitagawa8Department of Surgery, Kanagawa Children’s Medical Center, Yokohama, JapanDepartment of Surgery, Yokohama City University, Yokohama, JapanDepartment of Surgery, Kanagawa Children’s Medical Center, Yokohama, JapanDepartment of Surgery, Kanagawa Children’s Medical Center, Yokohama, JapanDepartment of Surgery, Kanagawa Children’s Medical Center, Yokohama, JapanDepartment of Surgery, Kanagawa Children’s Medical Center, Yokohama, JapanDepartment of Surgery, Kanagawa Children’s Medical Center, Yokohama, JapanDepartment of Surgery, Kanagawa Children’s Medical Center, Yokohama, JapanDepartment of Surgery, Kanagawa Children’s Medical Center, Yokohama, JapanPurposeSuperficial lymphatic malformation (SLM), previously known as lymphangioma circumscriptum, is characterized by skin lesions that sometimes require interventional treatment. However, an effective treatment has yet to be established. We proposed an effective sclerotherapy procedure based on the pathophysiology of SLM.MethodsSeven patients with SLM who were treated at our hospital between April 2015 and April 2024 were retrospectively enrolled. To maximize the treatment effects, sclerotherapy with bleomycin targeting the SLM and LM deep beneath the SLM was performed.ResultsOf the seven patients, four were females, and three were males. The SLM sites were mucosal lesions in four cases and skin lesions in three cases. The median age at the first sclerotherapy was 10 (1–18) years. A median of one course (1–3) of sclerotherapy resulted in a marked reduction of SLM lesions on gross evaluation to the satisfaction of the patient. The median observation period was 451 (59–2,901) days. No serious complications occurred, except for transient vomiting in one patient and temporary skin pigmentation in two patients. No patient experienced recurrence requiring retreatment.ConclusionOur study suggests that sclerotherapy for the SLM and LM deep beneath the SLM may be an effective treatment for SLM.https://www.frontiersin.org/articles/10.3389/fped.2025.1614095/fullsuperficial lymphatic malformationlymphatic malformationsclerotherapybleomycinvascular malformationspediatric surgery
spellingShingle Hidehito Usui
Hidehito Usui
Masato Shinkai
Satoshi Tanaka
Rento Morishima
Kazuki Shirane
Takafumi Kondo
Kyoko Mochizuki
Norihiko Kitagawa
Novel technique of sclerotherapy for superficial lymphatic malformation
Frontiers in Pediatrics
superficial lymphatic malformation
lymphatic malformation
sclerotherapy
bleomycin
vascular malformations
pediatric surgery
title Novel technique of sclerotherapy for superficial lymphatic malformation
title_full Novel technique of sclerotherapy for superficial lymphatic malformation
title_fullStr Novel technique of sclerotherapy for superficial lymphatic malformation
title_full_unstemmed Novel technique of sclerotherapy for superficial lymphatic malformation
title_short Novel technique of sclerotherapy for superficial lymphatic malformation
title_sort novel technique of sclerotherapy for superficial lymphatic malformation
topic superficial lymphatic malformation
lymphatic malformation
sclerotherapy
bleomycin
vascular malformations
pediatric surgery
url https://www.frontiersin.org/articles/10.3389/fped.2025.1614095/full
work_keys_str_mv AT hidehitousui noveltechniqueofsclerotherapyforsuperficiallymphaticmalformation
AT hidehitousui noveltechniqueofsclerotherapyforsuperficiallymphaticmalformation
AT masatoshinkai noveltechniqueofsclerotherapyforsuperficiallymphaticmalformation
AT satoshitanaka noveltechniqueofsclerotherapyforsuperficiallymphaticmalformation
AT rentomorishima noveltechniqueofsclerotherapyforsuperficiallymphaticmalformation
AT kazukishirane noveltechniqueofsclerotherapyforsuperficiallymphaticmalformation
AT takafumikondo noveltechniqueofsclerotherapyforsuperficiallymphaticmalformation
AT kyokomochizuki noveltechniqueofsclerotherapyforsuperficiallymphaticmalformation
AT norihikokitagawa noveltechniqueofsclerotherapyforsuperficiallymphaticmalformation